Knowledge

Current trends in data science for pharma – findings from a qualitative survey and what we should do about it!

By alexanderhschacht on 2019-02-19 0

Interview with Ursula Garczarek

Do you want to learn where the health sector might be heading in terms of data science?

Do you understand the opportunities and barriers in terms of the application of data science?

Are you prepared to learn the individual skills needed for these changes?

Then this interview with Ursula from Cytel provides you with the relevant answers. We are talking about:

[Read more…]

What you can learn about communication of statistics from a statistician working for the BBC

By alexanderhschacht on 2019-02-12 0

It’s surely not the norm, that a statistician from the pharma sector ends up working for BBC. But Robert Cuffe has taken this step and needs to explain statistics to non-statisticians on a daily basis.

In this episode, he shares the different methods he’s using. We also dive into common pitfalls, that we as statisticians trap into.

Finally, we also learn, how we can improve our publications to make sure, that the science is reported correctly in the broader news

[Read more…]

The rise of R and what role the AIMS SIG plays in it

By alexanderhschacht on 2019-01-29 0

Do you think, R can’t be used for regulatory submissions?
Are you forced to use SAS but would like to use R instead?
Would you like to understand how you can make R submission proof?

Then this interview with Lyn Tailor and Craig McIlloney helps you. Both work on the PSI special interest group Application and Implementation of Methodologies in Statistics (AIMS) on this topics.

Furthermore, we cover the following topics:

[Read more…]

How to work with key opinion leaders (KOLs)

By alexanderhschacht on 2018-12-18 0

KOLs play a major role in the health sector and professionally working together with them will boost your career! This episode provides you with lots of insights and tips.

However, to work successfully with key opinion leaders (KOLs) or key thought leaders (KTLs), you first need to understand the many different roles, they have. From the perspective of a pharmaceutical company, they are:

[Read more…]

Getting access for patients to new medications in Germany – the biggest challenges in the HTA process and how to address them: Interview with Carsten Schwenke

By alexanderhschacht on 2018-11-13 0

Today, regulatory approval doesn’t ensure anymore, that patients benefit from new therapies. As statisticians, we also need to ensure access and reimbursement for new treatments in the different markets around the world.

The process to gain this access and reimbursement in Germany comes with very specific challenges. Yet, due to the large impact of Germany on other countries via the complex reference pricing system and the size of the population of Germany, we must understand these topics.

Carsten Schwenke gathered experiences across therapeutic areas with many companies since the start of the new process in Germany. This makes him the most experienced and best connected statistician in the world for this topic.

[Read more…]

How to make the right portfolio decisions – Interview with Andreas Sashegyi

By alexanderhschacht on 2018-11-06 0

We’re all making decisions to optimize our studies. Optimizing project plans across different studies presents further challenges. But how to increase the overall portfolio of a company given its limitations leads yet another set of challenges. Knowing how decisions are taken at this top level helps to understand the bigger picture and why this sometimes implies sub-optimal decisions on a study or compound level.

[Read more…]